Clinical Trials
23 trialsNCT06032728 2023-09-13
Multimodal Recurrence Scoring System for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment
First Affiliated Hospital, Sun Yat-Sen University
Phase NA Not yet recruiting
NCT00656669 2023-05-23
Exploratory Study of Sunitinib Malate as a Component of Neoadjuvant Therapy for Breast Cancer
Indiana University
Phase NA Completed
NCT05816642 2023-04-18
Application Circulating Tumor DNA Dynamic Monitoring in Clinical Treatment of Metastatic Renal Cell Carcinoma
RenJi Hospital
Phase NA Unknown
NCT05751733 2023-03-02
Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST
Xiangya Hospital of Central South University
Phase NA Recruiting
NCT02450123 2022-06-15
Single-arm Study to Evaluate the Safety and Efficacy of Sunitinib, in Subjects With RET Fusion Positive or FGFR2 Amplification, Refractory Solid Tumors
Samsung Medical Center
Phase NA Completed
NCT01636908 2021-04-15
ICK
Amsterdam UMC, location VUmc
Phase NA Completed
NCT01190241 2020-11-20
TSAP
Amsterdam UMC, location VUmc
Phase NA Terminated
NCT02239952 2020-10-08
HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors)
Amsterdam UMC, location VUmc
Phase NA Unknown
NCT03571438 2020-01-18
COMBOREIN
University Hospital, Grenoble
Phase NA Unknown
NCT00428220 2019-06-27
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
Pfizer
Phase NA Completed
NCT01502228 2019-03-05
PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma
Indiana University
Phase NA Terminated
NCT03862768 2019-03-05
Role of Surgery in Patients With Focally Progressive Gastrointestinal Stromal Tumors (GISTs) After Imatinib Treatment
Shanghai Zhongshan Hospital
Phase NA Unknown
NCT01740154 2018-12-06
Sunitinib Malate Related Fatigue in Patients With Metastatic Kidney Cancer
Case Comprehensive Cancer Center
Phase NA Terminated
NCT00537056 2017-06-14
Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI
Stanford University
Phase NA Completed
NCT00943839 2016-11-10
Sunitinib Malate in Treating Patients With Kidney Cancer
Centre Antoine Lacassagne
Phase NA Completed
NCT01054911 2016-09-22
Evaluation of Patients With Bulky GIST Using Sunitinib
University of Alabama at Birmingham
Phase NA Terminated
NCT02013089 2016-08-30
GITIC
Sun Yat-sen University
Phase NA Unknown
NCT02688491 2016-02-25
A CpG-methylation-based Assay for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment
First Affiliated Hospital, Sun Yat-Sen University
Phase NA Not yet recruiting
NCT00531544 2016-01-05
A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248
King Faisal Specialist Hospital & Research Center
Phase NA Completed
NCT00849186 2015-02-06
Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer
Roswell Park Cancer Institute
Phase NA Completed
NCT02208128 2014-08-04
MORE
Heidelberg University
Phase NA Unknown
NCT00443534 2013-05-24
A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.
Pfizer
Phase NA Completed
NCT00798889 2013-01-21
Rollover Protocol for Prior SU011248 Protocols
Pfizer
Phase NA Completed